Optimi Health Corp. (CSE: OPTI)

Market Cap	21.77M
Revenue (ttm)	351.92K
Net Income (ttm)	-5.64M
Shares Out	94.66M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,257
Average Volume	70,907
Open	0.225
Previous Close	0.225
Day's Range	0.225 - 0.230
52-Week Range	0.180 - 0.540
Beta	1.20
RSI	55.58
Earnings Date	Jan 29, 2025

About Optimi Health

Optimi Health Corp. engages in the research, cultivation, processing, extraction, and distribution of psilocybin, psilocin, other psychedelic substances, and functional mushrooms for health and wellness markets in Canada and internationally. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of fungi varieties, including Lion’s Mane, Chaga, Reishi, Turkey Tail, and Cordyceps. It sells its products through www.optimilife.com, an e-commerce website platform; and Amazon marketplace, and distrib...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OPTI

Financial Performance

In 2023, Optimi Health's revenue was 181,087, an increase of 124.35% compared to the previous year's 80,717. Losses were -5.19 million, -29.33% less than in 2022.